Últimas noticias sobre CME Gr (NASDAQ:CME) Bolsa

CME Gr

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

CME Group Inc

CHINA MEIDONG AUTO HLDGS by China Meidong Auto Hldgs

China MeiDong Auto Holdings Ltd

CM ENERGY TECH CO LTD by CM ENERGY TECH CO LTD

CM Energy Tech Co Ltd

CREO MED GROUP LTD by CREO MED GROUP LTD.

Creo Medical Group PLC

CoinMerge (BEP-20)

CMONEY INC by cMoney, Inc.

CI MARRT ALT END YLD HGD SRS UNT ETF

CME GROUP CL A ORD

CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-10-23. Here's what investors need to know before the announcement.
Analysts estimate that CME Gr will report an earnings per share (EPS) of $2.57. 
The market awaits CME Gr's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Performance in Previous Earnings</h3>
The company's EPS beat by $0.03 in the last quarter, leading to a 1.08% increase in the share price on the following day.
Here's a look at CME Gr's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.53</td>
<td>2.45</td>
<td>2.28</td>
<td>2.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.56</td>
<td>2.50</td>
<td>2.37</td>
<td>2.25</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-0.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729616464_0.png" alt="eps graph" />
<h3>Performance of CME Gr Shares</h3>
Shares of CME Gr were trading at $227.05 as of October 21. Over the last 52-week period, shares are up 5.79%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CME/earnings">To track all earnings releases for CME Gr visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

What to Expect from CME Gr's Earnings

Morgan Stanley analyst Mike Cyprys maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Equal-Weight and raises the price target from $210 to $233.

News

Price Target

Analyst Ratings

Morgan Stanley Maintains Equal-Weight on CME Gr, Raises Price Target to $233

Oppenheimer analyst Owen Lau maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Outperform and raises the price target from $228 to $245.

Oppenheimer Maintains Outperform on CME Gr, Raises Price Target to $245

<ul>
<li>Record&nbsp;Europe,&nbsp;Middle East&nbsp;and&nbsp;Africa&nbsp;(EMEA) ADV&nbsp;of&nbsp;6.2M, up&nbsp;30%&nbsp;in&nbsp;Q3&nbsp;2024</li>
<li>Asia Pacific&nbsp;(APAC) ADV of&nbsp;1.8M, up&nbsp;28%</li>
</ul>

CME Group International ADV Reaches 8.4M Contracts In Q3 2024, Bolstered By 30% Growth In EMEA And 28% In APAC

Redburn Atlantic analyst Simon Clinch downgrades CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) from Buy to Neutral and announces $244 price target.

Downgrades

Redburn Atlantic Downgrades CME Gr to Neutral, Announces $244 Price Target

Piper Sandler analyst Patrick Moley maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Overweight and raises the price target from $225 to $240.

Piper Sandler Maintains Overweight on CME Gr, Raises Price Target to $240

Barclays analyst Benjamin Budish maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Equal-Weight and raises the price target from $209 to $219.

Barclays Maintains Equal-Weight on CME Gr, Raises Price Target to $219

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2024/10/02/final-trades-organon-howmet-and-the-psq.html">Halftime Report Final Trades</a>,&#8221; Bryn Talkington of Requisite Capital named Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) as her final trade.
On Wednesday, CEO Jensen Huang confirmed the company&#8217;s highly anticipated Blackwell chips are in full production. Huang appeared on CNBC&#8217;s Closing Bell Overtime on Wednesday and said Nvidia&#8217;s Blackwell chips are in production <a href="https://www.benzinga.com/news/large-cap/24/10/41169979/whats-going-on-with-nvidia-stock">and in high-demand.</a>
&#8220;Blackwell is in full production, Blackwell is as planned, and the demand for Blackwell is insane,&#8221; the Nvidia CEO said. &#8220;Everyone wants to have the most, and everyone wants to be first.&#8221;
Kevin Simpson of Capital Wealth Planning picked CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>).
On Oct. 2, CME reported market statistics for the third quarter and September month, with average daily volume reaching new, all-time records of 28.3 million contracts in the third quarter and 28.4 million contracts in the month of September.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Joshua Brown of Ritholtz Wealth Management named The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>).
On Oct. 2, Truist Securities analyst Youssef Squali maintained Trade Desk with a Buy and raised the price target from $108 to $120.
Price Action:
<ul>
<li>NVIDIA shares gained 3.4% to close at $122.85 during Thursday's session.</li>
<li>CME shares rose 0.3% to settle at $224.27 on Thursday.</li>
<li>Trade Desk shares gained 2.5% to close at $111.46 during Thursday's session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41179277/apogee-enterprises-smart-sand-and-3-stocks-to-watch-heading-into-friday">Apogee Enterprises, Smart Sand And 3 Stocks To Watch Heading Into Friday</a></li>
</ul>
Image: Shutterstock

Long Ideas

Markets

Media

Trading Ideas

NVDA

Nvidia, Trade Desk And A Financial Stock On CNBC's 'Final Trades'

Citigroup analyst Christopher Allen maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Buy and raises the price target from $240 to $250.

Citigroup Maintains Buy on CME Gr, Raises Price Target to $250

Goldman Sachs analyst Alexander Blostein maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Sell and raises the price target from $195 to $198.

Goldman Sachs Maintains Sell on CME Gr, Raises Price Target to $198

CNBC Halftime Report Final Trades: NVIDIA, CME Group, The Trade Desk

Live On CNBC, Kevin Simpson Announces Bought CME Group

RBC Capital analyst Ashish Sabadra reiterates CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Sector Perform and maintains $235 price target.

Reiteration

RBC Capital Reiterates Sector Perform on CME Gr, Maintains $235 Price Target

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Morgan Stanley raised the price target for Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) from $5 to $6. Morgan Stanley analyst Daniel Kutz maintained an Equal-Weight rating. Transocean shares fell 1.4% to close at $4.33 on Wednesday. <a href="https://www.benzinga.com/quote/RIG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho lowered the price target for Wolfspeed, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) from $17 to $8. Mizuho analyst Vijay Rakesh downgraded the stock from Neutral to Underperform. Wolfspeed shares gained 2.9% to close at $9.15 on Wednesday. <a href="https://www.benzinga.com/quote/WOLF/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group slashed Academy Sports and Outdoors, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>) price target from $65 to $60. Evercore ISI Group analyst Greg Melich downgraded the stock from Outperform to In-Line. Academy Sports and Outdoors shares fell 1.3% to close at $55.56 on Wednesday. <a href="https://www.benzinga.com/quote/ASO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank raised Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) price target from $600 to $620. Deutsche Bank analyst Scott Deuschle maintained a Buy rating. Lockheed Martin shares fell 0.4% to close at $603.20 on Wednesday. <a href="https://www.benzinga.com/quote/LMT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank slashed The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) price target from $225 to $195. Deutsche Bank analyst Scott Deuschle maintained a Buy rating. Boeing shares fell 0.9% to close at $152.89 on Wednesday. <a href="https://www.benzinga.com/quote/BA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities raised the price target for CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) from $177 to $180. B of A Securities analyst Craig Siegenthaler maintained an Underperform rating. CME fell 0.8% to close at $223.57 on Wednesday. <a href="https://www.benzinga.com/quote/CME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank raised GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) price target from $212 to $235. Deutsche Bank analyst Scott Deuschle maintained a Buy rating. GE Aerospace shares gained 0.1% to close at $186.44 on Wednesday. <a href="https://www.benzinga.com/quote/GE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler raised the price target for On Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) from $52 to $56. Piper Sandler analyst Anna Andreeva maintained an Overweight rating. On Holding shares fell 0.3% to close at $49.21 on Wednesday. <a href="https://www.benzinga.com/quote/ONON/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B. Riley Securities cut CoreCard Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCRD#NYSE">CCRD</a>) price target from $19 to $15. B. Riley Securities analyst Hal Goetsch downgraded the rating from Buy to Neutral. CoreCard shares fell 4.6% to close at $13.89 on Wednesday. <a href="https://www.benzinga.com/quote/CCRD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley cut New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) price target from $35 to $15. Morgan Stanley analyst Devin McDermott downgraded the stock from Overweight to Equal-Weight. New Fortress Energy shares fell 7.6% to close at $8.94 on Wednesday. <a href="https://www.benzinga.com/quote/NFE/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying GE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="512" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03081857/image-13-1024x512.png" alt="" class="wp-image-578508" style="width:618px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03081857/image-13-1024x512.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03081857/image-13-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03081857/image-13-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03081857/image-13.png 1342w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41156151/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>

Pre-Market Outlook

CCRD

ONON

WOLF

GE Aerospace To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday

B of A Securities analyst Craig Siegenthaler maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Underperform and raises the price target from $177 to $180.

B of A Securities Maintains Underperform on CME Gr, Raises Price Target to $180

CME Reported Its Q3 And September 2024 Market Statistics, With Average Daily Volume Reaching New, All-time Records Of 28.3M Contracts In Q3 And 28.4M Contracts In The Month Of September, And Growth Across All Asset Classes In Both Periods

CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) planned the expansion of its Nikkei 225 futures offerings by introducing yen- and U.S. dollar-denominated Micro Nikkei futures on <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41109808/cme-group-to-launch-yen-and-u-s-dollar-denominated-micro-nikkei-futures-on-october-28" rel="noreferrer noopener">October 28, pending regulatory approval</a>.
These new micro contracts, with contract sizes of 50 yen and $0.50, will allow traders to capture Japanese benchmark trading opportunities more precisely, enhancing CME Group&#8217;s current offerings of standard and E-mini Nikkei contracts.
Micro Nikkei futures will expand CME Group&#8217;s suite of micro equity futures contracts, which have traded over 2.9 billion contracts to date.
The recent trading highlights include 220 million cumulative Nikkei futures contracts traded since 2004, an average daily volume of 41,000 contracts year-to-date—up 9% year-over-year—and a year-to-date open interest of 67,000 contracts, reflecting a 2% increase year-over-year.
Paul Woolman, Global Head of Equity Index Products at CME Group, said, &#8220;The addition of micro-sized yen- and U.S. dollar-denominated Nikkei futures contracts will allow global market participants to gain efficient access to the broader Japanese stock market, while also mitigating FX exposure and allowing more granular trading capabilities.&#8221;
&#8220;Year-to-date, nearly 75% of trades in our Nikkei futures occurred outside of&nbsp;Tokyo&nbsp;cash hours, underscoring the need for around-the-clock liquidity for global market participants to manage their equity risk. Similar to their larger parent contacts, the smaller size futures contracts will also offer greater potential capital and margin efficiency.&#8221;
Last week, CME disclosed the expansion of its battery metals suite with the launch of a Spodumene CIF China (Fastmarkets) Futures contract set for <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/n41084773/cme-group-to-expand-battery-metals-suite-with-launch-of-spodumene-futures-on-october-28" rel="noreferrer noopener">October 28, 2024, pending regulatory approval</a>.
Investors can gain exposure to the stock via&nbsp;The Advisors? Inner Circle Fund Cambiar Aggressive Value ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAMX#NYSE">CAMX</a>) and iShares U.S. Broker-Dealers &amp; Securities Exchanges ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAI#NYSE">IAI</a>).
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40693687/cme-group-downgraded-analyst-sees-cutthroat-competition-from-bgc-group-cboe-global-" rel="noreferrer noopener">CME Group Downgraded: Analyst Sees Cutthroat Competition From BGC Group, Cboe Global &amp; Intercontinental Exchange</a>
Price Action: CME shares are up 0.03% at $220.71 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/09/40910280/as-fed-gears-up-for-cuts-one-hedge-funder-is-focused-on-a-bigger-catalyst-japans-central-bank" target="_blank" rel="noreferrer noopener">As Fed Gears Up For Cuts, One Hedge Funder Is Focused On A Bigger Catalyst: Japan&#8217;s Central Bank</a></li>
</ul>

Equities

Large Cap

CAMX

iShares Dow Jones US Broker Dealers Index Fund

CME Group Expands Nikkei Futures Offerings, Boosts Japanese Equity Derivatives

CME Group, the world's leading derivatives marketplace, today announced it will expand its suite of Nikkei 225 futures contracts with the addition of yen- and U.S. dollar-denominated Micro Nikkei futures on October 28, pending regulatory review.
Sized at 50 yen and $0.50, respectively, these new micro-sized contracts will allow traders to capture Japanese benchmark trading opportunities with greater precision and will add to CME Group's existing suite of standard and E-mini Nikkei contracts.
"The addition of micro-sized yen- and U.S. dollar-denominated Nikkei futures contracts will allow global market participants to gain efficient access to the broader Japanese stock market, while also mitigating FX exposure and allowing more granular trading capabilities," said Paul Woolman, Global Head of Equity Index Products at CME Group. "Year-to-date, nearly 75% of trades in our Nikkei futures occurred outside of Tokyo cash hours, underscoring the need for around-the-clock liquidity for global market participants to manage their equity risk. Similar to their larger parent contacts, the smaller size futures contracts will also offer greater potential capital and margin efficiency."
Micro Nikkei futures will join CME Group's growing suite of micro equity futures contracts, which have traded more than 2.9 billion contracts to date. The launch of Micro Nikkei futures also marks 20 years since the listing of the first Nikkei futures contracts on CME Globex in 2004. Recent trading highlights include:
<ul>
<li>220 million cumulative Nikkei futures contracts traded since 2004</li>
<li>Year-to-date average daily volume of 41,000 contracts, up 9% year-over-year</li>
<li>Year-to-date open interest of 67,000 contracts, up 2% year-over-year</li>
</ul>

CME Group To Launch Micro Nikkei Futures In Yen And US Dollars

CME Group, the world's leading derivatives marketplace, today announced that it will expand its battery metals suite and launch a Spodumene CIF China (Fastmarkets) Futures contract on October 28, 2024, pending regulatory review.
"Our suite of cobalt and lithium products serve an important role in the rapidly evolving battery metals space, with industry adoption accelerating," said Jin Hennig, Global Head of Metals at CME Group. "With this launch of Spodumene futures, we will expand hedging capabilities, making it easier for the market to manage the price differences across products in the lithium value chain."
"Albemarle welcomes CME Group's launch of spodumene futures, which complements the lithium market's evolving risk management needs," said Peter Hannah, Albemarle's Global Product Pricing Manager. "We recognize that trust in physical prices underpins confidence in futures trading, and are proud that our bidding event price discovery initiative has added valuable transparency to the spot market. The combination of liquid and robust physical and futures pricing mechanisms can help our industry grow."&nbsp;
"Developing a liquid and transparent lithium market is essential for all the players in the battery value chain and CME Group continues to work towards this goal," said Grant Donald, Chief Commercial Officer at Liontown. "A forward curve for key materials across the entire supply chain will be essential to effectively manage price risk for the rapidly growing clean energy market."
"The spodumene futures contract launch with the CME Group marks a significant step forward for the lithium market," said Raju Daswani, Chief Executive Officer at Fastmarkets. "With this contract, the industry gains a tool to manage price risk associated with the spodumene price, conversion margins, as well as take a view on the lithium conversion spread itself. We believe this will positively contribute to the liquidity across the entire battery raw materials futures complex," he added.
CME Group is the leading marketplace for managing battery metals risk. Open interest in Lithium Hydroxide futures surpassed 30,000 contracts for the first time this year and now extends through 2026. Open interest in Cobalt Metal futures also remains robust and extends through 2028, providing essential price transparency further along the curve.
Spodumene CIF China (Fastmarkets) futures will be financially-settled and will be listed by and subject to the rules of COMEX. <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4265499-1&amp;h=1556740351&amp;u=https%3A%2F%2Fwww.fastmarkets.com%2F&amp;a=Fastmarkets">Fastmarkets</a> is one of the most trusted cross-commodity price reporting agencies (PRA) in the agriculture, forest products, metals and mining, and new generation energy markets. For more information, please visit <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4265499-1&amp;h=2350756201&amp;u=https%3A%2F%2Fwww.cmegroup.com%2Fspodumene&amp;a=here">here</a>.

CME Group Expands Battery Metals Suite with Launch of Spodumene Futures in October

RBC Capital analyst Ashish Sabadra initiates coverage on CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Sector Perform rating and announces Price Target of $235.

Initiation

RBC Capital Initiates Coverage On CME Gr with Sector Perform Rating, Announces Price Target of $235

In a report released today, Daniel Fannon from Jefferies maintained a Buy rating on CME Group (CME – Research Report), with a price target of $254....

CME Group (CME) Gets a Buy from Jefferies

Mawer Investment Management Q2 2024 Quarterly Update

Thornburg Investment Income Builder Fund Q3 2024 Commentary

CME Group international average daily volume reached new record of 8.4M contracts in Q3

Upslope Capital's Q3 2024 Investor Letter

CME Group: An Attractive Business Relatively Out Of Favor

Pockets Of Value On The Long Side Despite Markets Sitting Near All-Time Highs

Morgan Stanley analyst Michael Cyprys maintained a Hold rating on CME Group (CME – Research Report) today and set a price target of $233.00. The co...

Morgan Stanley Sticks to Its Hold Rating for CME Group (CME)

Wakeup Call - It's Time To Buy High-Yield Dividends

RBC Capital analyst Ashish Sabadra maintained a Hold rating on CME Group (CME – Research Report) on October 18 and set a price target of $235.00. T...

CME Group (CME) Gets a Hold from RBC Capital

ASML

ASMLF

AVGO

AZNCF

BAMXF

BKRIF

BKRIY

BMWYY

BNPQF

BNPQY

BRRLY

BYCBF

BYCRF

BYMOF

BZLFF

BZLFY

CIGI

CMGMF

CMGMY

CMPGF

CMPGY

CMPO

CMPOW

DPLMF

DPMAY

DSFIY

DSMFF

DTEGF

DTEGY

ELEZF

ELEZY

ENLAY

ESOCF

FANG

FINGF

FNCTF

GLCNF

GLNCY

GRMN

IAFNF

JPXGY

KBGGY

KDDIF

KDDIY

KDSKF

LVMHF

LVMUY

MHVIY

MHVYF

MONOF

MONOY

NNGPF

NNGRY

NNWWF

NONOF

NSKFF

ORAN

OSCUF

REXR

RHHBF

RHHBY

RHHVF

SGAPY

SNGNF

SOBO

SSNLF

TSCDF

TSCDY

TSMWF

TTFNF

VICI

VNOM

VODPF

WIPKF

Screenshot 2024-05-07 at 5.26.30 PM

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

With The Cryptocurrency Market Historically Tumultuous, Regulated Futures Brokers Like EdgeClear May Offer More Security Than Their Spot Counterparts

Press Releases

CME Group SOFR Futures Reach New Volume and Open Interest Records

CME Group to Expand Battery Metals Suite with Launch of Spodumene Futures on October 28

Fintech

Commodities

CME Group to Launch Yen- and U.S. Dollar-denominated Micro Nikkei Futures on October 28

Farmer sentiment reaches lowest levels since 2016 as income expectations weaken

Bitcoin Friday Futures Become Most Successful CME Group Cryptocurrency Product Launch

CME Group Sets New, All-Time Quarterly and September ADV Records Driven by Growth Across All Asset Classes

CME Group to Launch Options on E-mini Select Sector Futures and Dow Jones U.S. Real Estate Index Futures on October 28

Trading in Tuesday and Thursday Crude Oil Options Surpasses 100,000 Contracts as Demand Soars

CME Group International Average Daily Volume Reached New Record of 8.4 Million Contracts in Q3 2024

CME Group Announces First Trades of CBL Australian Carbon Credit Unit (ACCU) Futures

Comments

CME Gr

Noticias

Últimas noticias sobre CME Gr (NASDAQ:CME) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL